U.S. medical tech company Edwards Lifesciences buys Israel’s Innovalve Bio Medical
Categories: Corporate and M&A
The U.S. listed medical device giant, Edwards Lifesciences is set to acquire Innovalve Bio Medical, an Israeli medtech company specializing in trans-catheter mitral valve replacements.
While the exact financial terms remain undisclosed, industry insiders project the transaction to exceed USD 300 million. Edwards has exercised its option to purchase Innovalve, marking a significant investment in innovative healthcare technology.
FBC & Co. advised Edwards Lifesciences on the transaction. The FBC team was led by Raz Tepper, M&A partner and co-head of the Hi-Tech, Technology, and Venture Capital practice; partner Sharon Klein-Manbar and associate Ori Cohen from the practice. The team worked closely with the Tax, Competition and Antitrust, Cybersecurity, IT & Data Protection, and Labor and Employment practices.
Gibson, Dunn & Grutcher led the transaction in the U.S.
